Skip to main content

FDA recall, , Moderate risk

Philips Azurion

Philips Azurion x-ray system has software issues that may delay therapy and cause procedural complications.

What happened

Philips Medical Systems Nederland B.V., located in Best, Netherlands, recalled its Philips Azurion interventional fluoroscopic x-ray system, models 722229 through 722236, with software versions R3.0 and R3.1. The recall began July 16, 2026, and the FDA added it to its Enforcement Report on August 10, 2026.

Two software related issues affect the systems: potential image quality degradation that may lead to delay of therapy, procedural complications and/or inappropriate treatment, and potential loss of geometry movements that may lead to delay of therapy and procedural complications. Distribution is worldwide.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its model number and UDI-DI are listed under that product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Philips Azurion

    Model number
    • 722229
    • 722230
    • 722231
    • 722232
    • 722233
    • 722234
    • 722235
    • 722236
    UDI-DI
    • 00884838116757
    • 00884838116771
    • 00884838116801
    • 00884838116733
    • 00884838116764
    • 00884838116788
    • 00884838116740
    • 00884838116726
    • 0088483811680

Recall details

Company began the recall
Sold in

Worldwide distribution.

Company
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Best, Netherlands
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99423
Recall number
Z-2932-2026
Quantity recalled
2016 units

All recalls from PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)